Government ❯ Public Health

Pandemic Response

COVID-19 Covid-19 Mask Procurement COVID-19 Measures PPE Procurement COVID-19 Regulations COVID-19 Management Monitoring and Tracking Funding Stockpiles Elderly Care Policies Lockdown Policies Nursing Homes Elderly Care Healthcare Oversight Vaccine Development Economic Measures Policy Analysis Evaluation Vaccine Procurement Resource Allocation PPE Supply Chain Personal Protective Equipment PPE Supply Vaccine Distribution Lockdown Measures Contract Management Laboratory Facilities International Cooperation COVID-19 Impact Healthcare Access Medical Supplies Vaccination Policies Medical Equipment Exchange Political Accountability Covid-19 Measures Health Guidelines Covid-19 Management COVID-19 Testing

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.